The genetic and epigenetic landscape for CNS drug discovery targeting cross-diagnostic behavioral domains

被引：4
|
作者：
de Mooij-van Malsen, Annetrude [1 ,2 ]
Pjetri, Eneda [1 ,3 ]
Kas, Martien J. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands
[2] CAU Kiel, Inst Physiol, Kiel, Germany
[3] UNC Chapel Hill Nutr Res Inst, Kannapolis, NC 28081 USA
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 2015年 / 753卷
关键词：
Behavior; Psychiatry; Drug targets; Endophenotypes; Mouse; Human; MOUSE AVOIDANCE-BEHAVIOR; GENOME-WIDE ASSOCIATION; BIPOLAR DISORDER; EATING-DISORDERS; MOOD DISORDER; SCHIZOPHRENIA; MICE; SUSCEPTIBILITY; CONSORTIUM; SEQUENCE;
D O I：
10.1016/j.ejphar.2014.07.043
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Animal studies play a central role in the identification and testing of novel drugs for CNS disorders. In his longstanding career, Berend Olivier has significantly contributed to CNS drug discovery by applying and supporting novel views and methodologies in the fields of behavioral neuroscience, pharmacology, and (epi-) genetics. Here we review and put forward some of these integrated approaches that have led to a productive collaboration and new insights into the genetic and epigenetic regulation of neurobehavioural traits related to psychiatric disorders. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码：135 / 139
页数：5
相关论文
共 34 条
  • [21] Behavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug Addiction
    Mayfield, Jody
    Blednov, Yuri A.
    Harris, R. Adron
    STRUCTURE TO FUNCTION OF G PROTEIN- GATED INWARDLY RECTIFYING (GIRK) CHANNELS, 2015, 123 : 279 - 313
  • [22] Deep Learning for Cross-Diagnostic Prediction of Mental Disorder Diagnosis and Prognosis Using Danish Nationwide Register and Genetic Data
    Allesoe, Rosa Lundbye
    Thompson, Wesley K. K.
    Bybjerg-Grauholm, Jonas
    Hougaard, David M. M.
    Nordentoft, Merete
    Werge, Thomas
    Rasmussen, Simon
    Benros, Michael Eriksen
    JAMA PSYCHIATRY, 2023, 80 (02) : 146 - 155
  • [23] Functional outcome in major psychiatric disorders and associated clinical and psychosocial variables: A potential cross-diagnostic phenotype for further genetic investigations?
    Gade, Katrin
    Malzahn, Doerthe
    Anderson-Schmidt, Heike
    Strohmaier, Jana
    Meier, Sandra
    Frank, Josef
    Falkai, Peter G.
    Rietschel, Marcella
    Schulze, Thomas G.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2015, 16 (04): : 237 - 248
  • [24] Therapeutic targeting Tudor domains in leukemia via CRISPR-Scan Assisted Drug Discovery
    Chan, Anthony K. N.
    Han, Li
    Delaney, Christopher D.
    Wang, Xueer
    Mukhaleva, Elizaveta
    Li, Mingli
    Yang, Lu
    Pokharel, Sheela Pangeni
    Mattson, Nicole
    Garcia, Michelle
    Wang, Bintao
    Xu, Xiaobao
    Zhang, Leisi
    Singh, Priyanka
    Elsayed, Zeinab
    Chen, Renee
    Kuang, Benjamin
    Wang, Jinhui
    Yuan, Yate-Ching
    Chen, Bryan
    Chan, Lai N.
    Rosen, Steven T.
    Horne, David
    Muschen, Markus
    Chen, Jianjun
    Vaidehi, Nagarajan
    Armstrong, Scott A.
    Su, Rui
    Chen, Chun-Wei
    SCIENCE ADVANCES, 2024, 10 (08):
  • [25] Altered immediate behavioral response to partial social exclusion: A cross-diagnostic study in patients with borderline personality disorder and persistent depressive disorder
    Barton, Barbara B.
    Goerigk, Stephan
    Wustenberg, Torsten
    Dewald-Kaufmann, Julia
    Reinhard, Matthias A.
    Musil, Richard
    Ehring, Thomas
    Jobst, Andrea
    Padberg, Frank
    JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 144 : 177 - 183
  • [26] Effects of repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex on symptom domains in neuropsychiatric disorders: a systematic review and cross-diagnostic meta-analysis
    Kan, Rebecca L. D.
    Padberg, Frank
    Giron, Cristian G.
    Lin, Tim T. Z.
    Zhang, Bella B. B.
    Brunoni, Andre R.
    Kranz, Georg S.
    LANCET PSYCHIATRY, 2023, 10 (04): : 252 - 259
  • [27] Defining Neuropharmacokinetic Parameters in CNS Drug Discovery to Determine Cross-Species Pharnnacologic Exposure-Response Relationships
    Shaffer, Christopher L.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45, 2010, 45 : 55 - 70
  • [28] Deep Learning for Cross-Diagnostic Prediction of Mental Disorder Diagnosis and Prognosis Using Danish Nationwide Register and Genetic Data (vol 80, pg 146, 2023)
    Allesoe, R. L.
    Thompson, W. K.
    Bybjerg-Grauholm, J.
    JAMA PSYCHIATRY, 2023, 80 (06) : 651 - 651
  • [29] Investigation of the Genome-Wide Genetic and Epigenetic Networks for Drug Discovery Based on Systems Biology Approaches in Colorectal Cancer
    Yeh, Shan-Ju
    Chen, Shuo-Wei
    Chen, Bor-Sen
    FRONTIERS IN GENETICS, 2020, 11
  • [30] Drug discovery targeting epigenetic codes: The great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis
    Unoki, Motoko
    Brunet, Julie
    Mousli, Marc
    BIOCHEMICAL PHARMACOLOGY, 2009, 78 (10) : 1279 - 1288
1234